0 CHECKOUT

PRODUCT FILTERS

REGION

138
20
13
13
11

COUNTRY

6
4
4
4
3

PRICE

86
117
278
503

PUBLISHED

1
8
131
503

PRODUCT TYPE

498
3
1
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

503 Products

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015 Summary This, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

Published:  January 2015
Price:  From

Ragweed Allergy - Pipeline Review, H1 2015

Ragweed Allergy - Pipeline Review, H1 2015 Summary This, ‘Ragweed Allergy - Pipeline Review, H1 2015’, provides an overview of the Ragweed Allergy’s therapeutic pipeline. This report provides comprehensive...

Published:  January 2015
Price:  From

House Dust Mite Allergy - Pipeline Review, H1 2015

House Dust Mite Allergy - Pipeline Review, H1 2015 Summary This, ‘House Dust Mite Allergy - Pipeline Review, H1 2015’, provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This...

Published:  January 2015
Price:  From

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

Published:  January 2015
Price:  From

Birch Pollen Allergy - Pipeline Review, H1 2015

Birch Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Birch Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Birch Pollen Allergy’s therapeutic pipeline. This report...

Published:  January 2015
Price:  From

Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity...

Published:  December 2014
Price:  From

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

Published:  December 2014
Price:  From

RAVAX (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

RAVAX (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects...

Published:  December 2014
Price:  From

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Clazakizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

Published:  December 2014
Price:  From

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

Published:  December 2014
Price:  From

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints...

Published:  December 2014
Price:  From

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints....

Published:  December 2014
Price:  From

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

Published:  December 2014
Price:  From

Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

Published:  December 2014
Price:  From

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints...

Published:  December 2014
Price:  From

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Xeljanz (tofacitinib) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

Published:  December 2014
Price:  From

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity...

Published:  December 2014
Price:  From

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

Published:  December 2014
Price:  From

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

Published:  December 2014
Price:  From
Loading Indicator

Our Clients